COVID drug trial for kids halted early
NCT ID NCT05074420
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the drug baricitinib in children aged 1 to 18 who were hospitalized with COVID-19 and needed extra oxygen. The goal was to see if the drug was safe and how it worked in kids. Only 6 children took part before the study was stopped early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arnold Palmer Hospital for Children
Orlando, Florida, 32806, United States
-
CECIP - Centro de Estudos do Interior Paulista
Jaú, 17201130, Brazil
-
Centro de Pesquisa Sao Lucas
Campinas, 13034-685, Brazil
-
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
-
Complejo Hospitalario de Navarra
Pamplona, 31009, Spain
-
Hospital Infantil de Mexico Federico Gomez
Mexico City, 06720, Mexico
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario de Araba (HUA)- Hospital Txagorritxu
Vitoria-Gasteiz, 01009, Spain
-
Hospital de Clinicas de Porto Alegre
Porto Alegre, 90410000, Brazil
-
Instituto Nacional de Pediatria
Mexico City, 04530, Mexico
-
Instituto de Pesquisa clinica de Campinas
Campinas, 13060-080, Brazil
-
Pesquisare Saude
Santo André, 09080-110, Brazil
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19
- Experimental drug aims to tame severe COVID-19 inflammation
- Malaria drug combo shows promise against COVID-19 in early trial